1 |
Wang A, Zhang H, Liu J, Yan Z, Sun Y, Su W, Yu JG, Mi J, Zhao L. Targeted Lipidomics and Inflammation Response to Six Weeks of Sprint Interval Training in Male Adolescents. Int J Environ Res Public Health 2023;20. [PMID: 36834025 DOI: 10.3390/ijerph20043329] [Reference Citation Analysis]
|
2 |
Su L, Xiu M, Guan X, Wu F. Lysophosphatidylethanolamine correlated with cognitive improvements after treatment with olanzapine in drug-naïve first-episode schizophrenia: a prospective cohort study.. [DOI: 10.21203/rs.3.rs-2339101/v1] [Reference Citation Analysis]
|
3 |
Fei Wang, Lin Guo, Ting Zhang, Zhiquan Cui, Jinke Wang, Chi Zhang, Fen Xue, Cuihong Zhou, Baojuan Li, Qingrong Tan, Zhengwu Peng. Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder. Medicina (Kaunas) 2022;58:1509. [PMID: 36363466 DOI: 10.3390/medicina58111509] [Reference Citation Analysis]
|
4 |
Guan X, Xu J, Xiu M, Li X, Liu H, Wu F. Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study. CNS Neurosci Ther 2022. [PMID: 35769008 DOI: 10.1111/cns.13895] [Reference Citation Analysis]
|